Theme morning: Patient involvement in drug decisions - presentation François Houÿez

On 1 October 2015, representatives of approximately 30 patient organisations joined the Medicines Evaluation Board (MEB) to discuss the options for (increased) involvement of patients in decisions about the authorisation and monitoring of medicines. The meeting was followed by the official appointment in the afternoon by the MEB of Annemiek van Rensen as the new Board member for Patient and Consumer Perspective.